Healthcare
Live Price
Offline$2.22
+9.90% today
1Y Change
+64.44%
Window
Jun 23, 2025 → Jun 18, 2026
Coverage: 249 bars · Jun 23, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Protalix BioTherapeutics, Inc. (PLX) is a Healthcare stock with a market cap of $170.00M and listed on AMEX. The stock last traded around $2.22 and up 64.4% across the available one-year price window (Jun 23, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of -1.2%, EPS growth of -308.2%, a dividend yield of 0.0%. What stands out right now is revenue -1.2%, EPS -308.2%, free cash flow -284.4% with operating margin -10.4% and ROIC -9.6%. Valuation is more restrained than many high-expectation growth names at price/sales 3.2. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines PLX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PLX
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
PLX Max Drawdown
-39.68%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for PLX and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
Latest Revenue
—
Latest Net Income
—
Free Cash Flow
—
Revenue Growth
-1.2%
EPS Growth
-308.2%
Gross Margin
48.8%
Net Margin
-12.5%
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.